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Table S1 Participant information for human serum samples from pregnant and non-pregnant women 
  
Non-
pregnant Pregnant* Significance 
n 12 15   
Age (y) 28.50 29.25 0.84 
BMI 23.70 24.80 0.53 
BGC fasting (mM) 5.12 4.13 4.78E-05 
BGC +2 h (mM) 6.36 5.43 0.10 
HbA1C 34.20 30.73 0.04 
*OGTT at 28 weeks’ gestation 
BGC, blood glucose concentration; BMI, body mass index (based on weight (kg)/height (m) squared).   +120 min refers to samples that were taken a num-
ber of minutes after ingestion of glucose (75 g) at fasting.  
 
 
Table S2 Participant information for human placenta samples from Pregnancy Outcome Prediction Study 
  Lean Obese Significance 
n 39 40 - 
Age (y) 30.77 29.73 0.026 
BMI 33.37 21.06 5.6 × 10-25 
Male offspring (%) 58 28 - 














Homogenisation Storage Further dilution Vol. used in lipid 
extraction (µL) 
Human serum n/a 0 0 - -80 °C n/a 20 
Mouse serum n/a 0 0 - -80 °C n/a 20 
Mouse adipose ~250  2 n/a TissueRuptor II -80 °C Methanol (400 µL) and 
TBME (100 µL) 
8 
Mouse brain ~450  2 n/a TissueRuptor II -80 °C n/a 30  
Mouse kidney ~200 1 n/a TissueRuptor II -80 °C n/a 50 
Mouse liver ~400 2 n/a TissueRuptor II -80 °C n/a 10 
Mouse heart ~100 1 1× Pestle & mortar* -80 °C n/a 50 
Mouse vastus 
muscle 
~150  0.6 3×, 1× after 
homog.** 
TissueRuptor II† -80 °C n/a 50 
Human placenta 
(portion) 
30-40  0.7 n/a TissueRuptor II -80 °C n/a 50 
*Before being dispersed in GCTU, samples ground to a powder at -78 °C.  **Samples were checked for the presence of further solid 
material after freeze-thawing, those with solid material were homogenized again.  † Samples were centrifuged briefly after homogenization, 




Table S4 List of internal standards used for lipid profiling in the present study 
Lipid Class Isoform 
Cholesteryl ester CE(18:0-d6 ) 
Ceramide C16-d31 Ceramide 
Fatty acid  C15:0-d29 FA 
Fatty acid  C17:0-d33 FA 
Fatty acid  C20:0-d39 FA 
lyso-Phosphatidylcholine lysoPC(C14:0)-d42 
Phosphatidic acid PA(C16:0-d31/C18:1) Na+ salt 
Phosphatidylcholine PC(C16:0-d31/C18:1) 
Phosphatidylethanolamine PE(C16:0-d31/C18:1) 
Phosphatidylglycerol PG(C16:0-d31/C18:1) Na+ salt 
Phosphatidylinositol PI(C16:0-d31/C18:1) NH4+ salt 
Phosphatidylserine PS(C16:0-d62) Na+ salt 
Sphingomyelin SM(C16:0-d31) 
Triglyceride  TG(45:0-d29) 
Triglyceride  TG(48:0-d31) 









LC-MS used to determine the FA profile of phospholipid variables 
  
 
Fig. S1 Analysis of PC(36:6) using LC-MS in both positive and negative ionization modes with collision induced dissociation (CID): 





31P NMR used to investigate the shift in phospholipid profile between kidneys of lean and obese mice 
 
Fig. S2 Stacked, deconvoluted, 1D 31P NMR spectra from pooled mouse kidney samples collected from lean and obese post-weaning 
dams. Phosphatidylethanolamine signals appear at 0·56, 0·53, 0·21, 0·17 ppm (See Fig. S4) 
 
 
 31P NMR used to investigate the shift in phospholipid profile between pregnant and non-pregnant samples 
 
Fig. S3 Stacked, deconvoluted, 1D 31P NMR spectra from pooled human serum samples collected from pregnant and non-pregnant women 





2D-31P NMR used to investigate the configuration of lipids associated with 1D 31P resonances 
 
Fig. S4 31P-HSQC spectrum of kidney from obese post-weaning mouse dams. This suggests that phosphatidylethanolamine signals appear 
at 0·56, 0·53, 0·21, 0·17 ppm (Unk1, Unk2), that PCplas has a shift of 0·05 ppm and that the resonances for SM and PC can be split as well 
as those for PG and PE.  CL, cardiolipin; LPC, lyso-phosphatidylcholine; PC, phosphatidylcholine; PCplas, plasamalogen-
phosphatidylcholine; PE, phosphatidylethanolamine; PEplas, plasmalogen-phosphatidylethanolamine; PG, Phosphatidylglycerol; PI, phos-










Fig. S5 The average relative abundance of phospholipid classes in the livers (top) and brains (bottom) of lean and obese groups of mice.  


















































































Activity of FADS2 through ratio of abundance of TG(50:3) with TG(50:2) from lean and obese mouse tissues 
 
Fig. S6 The ratio of TG(50:03)/ TG(50:02) in tissues from lean and obese mice. Values calculated from the mean relative abundance of the 
TG(50:03) divided by the mean relative abundance of TG(50:02) (see signals sheets for calculations).  This ratio implies the activity of 
fatty acid desaturase 2 (FADS2). 
 
Unsupervised multivariate analysis of the lipid profile of sera from pregnant and non-pregnant women 
 
Fig. S7 Principal component analysis of the lipid profiles of serum samples from pregnant and non-pregnant women both at fasting 
(000 min) and 120 min after ingestion of glucose (75 g) 
  






























Abundance of phospholipids that change significantly between pregnant and non-pregnant women at fasting at 2 h post 
prandial 
 
Fig. S8 Abundance of lipids in serum samples from pregnant and non-pregnant women both at fasting (0 h) and 2 h after ingestion of 












































































































































































































































































31P NMR used to investigate the shift in phospholipid profile between lean and obese placenta samples 
 
Fig. S9 Stacked, deconvoluted, 1D 31P NMR spectra from pooled human placentae samples collected from lean and obese vaginal single-
ton male births. Phosphatidylethanolamine signals appear at 0·54, 0·24, 0·18 ppm, See Fig. S4 
